Pharmacology
News
FDA okays difelikefalin for dialysis-associated pruritus in patients with CKD
Pruritus in patients with chronic kidney disease on hemodialysis is common and has had no widely accepted go-to treatment.
Commentary
‘Countdown to zero’: Endocrine disruptors and worldwide sperm counts
A urologist makes the case that everyday chemicals are behind the ongoing decline in sperm counts seen in Western countries.
News
Parental smoking linked to more adult RA in women
Adjusted analysis suggests a 75% boost in risk, although overall rate is low.
News
Tocilizumab shortage continues as pandemic wears on
Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory...
News
Pfizer recalls four more lots of smoking cessation drug Chantix
On July 2, the FDA reported that Pfizer had voluntarily recalled nine lots of the drug.
News
‘Reassuring’ findings for second-generation antipsychotics during pregnancy
“For women with major mood and/or psychotic disorders, treatment with an atypical antipsychotic during pregnancy may be the most prudent clinical...
News
‘No justification’ for suicide warning on all antiseizure meds
“How many patients are afraid of their medication and do not take it because of the warning?”
News
Half abandon metformin within a year of diabetes diagnosis
Multiple factors are blamed for the drop-off, while improved communication, follow-up, and medication adjustment are advised as remedies.
Latest News
Bone drugs for prostate cancer may result in survival benefit
Retrospective study shows the addition of bone resorption inhibitors to abiraterone, plus prednisolone, may lengthen survival.
News
Diabetes drug’s new weight-loss indication fuels cost-benefit debate
Health plans’ coverage of semaglutide, branded as Wegovy – which has a $1,300-a-month price tag – is not a sure thing.